| Autor: |
Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Drug Design, Development and Therapy, Vol Volume 13, Pp 807-808 (2019) |
| Druh dokumentu: |
article |
| ISSN: |
1177-8881 |
| Popis: |
Abe M, Tsushima K, Sakayori M, et al. Drug Des Devel Ther. 2018;12:3369–3375.On page 3372, last paragraph of “Results” section should read from “In Severe Group, patients who were able to continue nintedanib for more than 3 months (n = 4) exhibited significantly better prognosis compared to those who could not (n = 13) (P = 0.007) (Figure 6).” to “In Severe Group, patients who were able to continue nintedanib for more than 3 months (n = 13) exhibited significantly better prognosis compared to those who could not (n = 4) (P = 0.007) (Figure 6).”Read the orginal article |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
